Morphosys Ag (MOR) has released an update.
MorphoSys AG has announced a significant change in shareholding, with Novartis AG acquiring a new total of 91.04% of voting rights as of June 19, 2024. The acquisition marks a substantial increase from the previous notification, indicating a major shift in the company’s ownership structure. This strategic move by Novartis signals a strong commitment to MorphoSys AG’s future.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.
